| Logo Mark Life Science Institute, Inc.
88880733 21 Apr 2020 | on 31 May 2022
| Cells for medical use; Stem cells for medical use; Pharmaceutical prep... Class 005 Class 005 Pharmaceutical Products The mark consists of a hollow sphere design outlined by brush-strokes resembling blue, red, and white ribbons. The upper left part of the sphere has a blue stripe going to the bottom left, having a gleam and showing color gradation. The bottom part to the right side of sphere is outlined by a navy blue stripe. There is also a thin red stripe across the center of the sphere from the top to the bottom, and a white streak from the top right to the bottom left of the sphere. The light blue ribbon does not touch the dark blue ribbon. The background on which the design is placed and the center of the sphere represents transparent area. | | | LSII Life Science Institute, Inc.
88739792 26 Dec 2019 | on 08 Mar 2022
| Cells for medical use; Stem cells for medical use; Pharmaceutical prep... Class 005 Class 005 Pharmaceutical Products Cells for medical use; Stem cells for medical use; Pharmaceutical preparations containing cells for treatment of hypoxic-ischemic encephalopathy, epidermolysis bullosa, cerebral infarction, stroke apoplexia cerebri, acute myocardial infarction and spinal cord injuries; pharmaceutical preparations containing stem cells for treatment of hypoxic-ischemic encephalopathy, epidermolysis bullosa, cerebral infarction, stroke apoplexia cerebri, acute myocardial infarction and spinal cord injuries; pharmaceutical composition containing cells for treatment of hypoxic-ischemic encephalopathy, epidermolysis bullosa, cerebral infarction, stroke apoplexia cerebri, acute myocardial infarction and spinal cord injuries; pharmaceutical composition containing stem cells for treatment of hypoxic-ischemic encephalopathy, epidermolysis bullosa, cerebral infarction, stroke apoplexia cerebri, acute myocardial infarction and spinal cord injuries | | | LSII Life Science Institute, Inc.
88393497 19 Apr 2019 | on 23 Mar 2021
| Cells for medical use; Stem cells for medical use; Pharmaceutical prep... Class 005 Class 005 Pharmaceutical Products Cells for medical use; Stem cells for medical use; Pharmaceutical preparations containing cells for treatment of epidermolysis bullosa, cerebral infarction, stroke [apoplexia cerebri], acute myocardial infarction and spinal cord injuries; pharmaceutical preparations containing stem cells for treatment of epidermolysis bullosa, cerebral infarction, stroke [apoplexia cerebri], acute myocardial infarction and spinal cord injuries; pharmaceutical composition containing cells for treatment of epidermolysis bullosa, cerebral infarction, stroke [apoplexia cerebri], acute myocardial infarction and spinal cord injuries; pharmaceutical composition containing stem cells for treatment of epidermolysis bullosa, cerebral infarction, stroke [apoplexia cerebri], acute myocardial infarction and spinal cord injuries | | | SSEACHYM Life Science Institute, Inc.
88250264 04 Jan 2019 | on 03 Nov 2020
| Cells for medical use; stem cells for medical purposes; pharmaceutical... Class 005 Class 005 Pharmaceutical Products Cells for medical use; stem cells for medical purposes; pharmaceutical preparations containing cells for treatment of epidermolysis bullosa, cerebral infarction, stroke being apoplexia cerebri, acute myocardial infarction and spinal cord injuries; pharmaceutical preparations containing stem cells for treatment of epidermolysis bullosa, cerebral infarction, stroke being apoplexia cerebri, acute myocardial infarction and spinal cord injuries; pharmaceutical composition containing cells for treatment of epidermolysis bullosa, cerebral infarction, stroke being apoplexia cerebri, acute myocardial infarction and spinal cord injuries; pharmaceutical composition containing stem cells for treatment of epidermolysis bullosa, cerebral infarction, stroke being apoplexia cerebri, acute myocardial infarction and spinal cord injuries | | | SSEAMCYTE Life Science Institute, Inc.
88250267 04 Jan 2019 | on 03 Nov 2020
| Cells for medical use; stem cells for medical purposes; pharmaceutical... Class 005 Class 005 Pharmaceutical Products Cells for medical use; stem cells for medical purposes; pharmaceutical preparations containing cells for treatment of epidermolysis bullosa, cerebral infarction, stroke being apoplexia cerebri, acute myocardial infarction and spinal cord injuries; pharmaceutical preparations containing stem cells for treatment of epidermolysis bullosa, cerebral infarction, stroke being apoplexia cerebri, acute myocardial infarction and spinal cord injuries; pharmaceutical composition containing cells for treatment of epidermolysis bullosa, cerebral infarction, stroke being apoplexia cerebri, acute myocardial infarction and spinal cord injuries; pharmaceutical composition containing stem cells for treatment of epidermolysis bullosa, cerebral infarction, stroke being apoplexia cerebri, acute myocardial infarction and spinal cord injuries | | | LURITECY Life Science Institute, Inc.
88250278 04 Jan 2019 | on 03 Nov 2020
| Cells for medical use; stem cells for medical purposes; pharmaceutical... Class 005 Class 005 Pharmaceutical Products The wording "LURITECY" has no meaning in a foreign language. | | | LYFMUZE Life Science Institute, Inc.
88250273 04 Jan 2019 | on 03 Nov 2020
| Cells for medical use; stem cells for medical purposes; pharmaceutical... Class 005 Class 005 Pharmaceutical Products Cells for medical use; stem cells for medical purposes; pharmaceutical preparations containing cells for treatment of epidermolysis bullosa, cerebral infarction, stroke being apoplexia cerebri, acute myocardial infarction and spinal cord injuries; pharmaceutical preparations containing stem cells for treatment of epidermolysis bullosa, cerebral infarction, stroke being apoplexia cerebri, acute myocardial infarction and spinal cord injuries; pharmaceutical composition containing cells for treatment of epidermolysis bullosa, cerebral infarction, stroke being apoplexia cerebri, acute myocardial infarction and spinal cord injuries; pharmaceutical composition containing stem cells for treatment of epidermolysis bullosa, cerebral infarction, stroke being apoplexia cerebri, acute myocardial infarction and spinal cord injuries | | | NYFOLMO Life Science Institute, Inc.
88250281 04 Jan 2019 | on 03 Nov 2020
| Cells for medical use; stem cells for medical purposes; pharmaceutical... Class 005 Class 005 Pharmaceutical Products Cells for medical use; stem cells for medical purposes; pharmaceutical preparations containing cells for treatment of epidermolysis bullosa, cerebral infarction, stroke being apoplexia cerebri, acute myocardial infarction and spinal cord injuries; pharmaceutical preparations containing stem cells for treatment of epidermolysis bullosa, cerebral infarction, stroke being apoplexia cerebri, acute myocardial infarction and spinal cord injuries; pharmaceutical composition containing cells for treatment of epidermolysis bullosa, cerebral infarction, stroke being apoplexia cerebri, acute myocardial infarction and spinal cord injuries; pharmaceutical composition containing stem cells for treatment of epidermolysis bullosa, cerebral infarction, stroke being apoplexia cerebri, acute myocardial infarction and spinal cord injuries | | | MARCHYMEL Life Science Institute, Inc.
88250286 04 Jan 2019 | on 03 Nov 2020
| Cells for medical use; stem cells for medical purposes; pharmaceutical... Class 005 Class 005 Pharmaceutical Products Cells for medical use; stem cells for medical purposes; pharmaceutical preparations containing cells for treatment of epidermolysis bullosa, cerebral infarction, stroke being apoplexia cerebri, acute myocardial infarction and spinal cord injuries; pharmaceutical preparations containing stem cells for treatment of epidermolysis bullosa, cerebral infarction, stroke being apoplexia cerebri, acute myocardial infarction and spinal cord injuries; pharmaceutical composition containing cells for treatment of epidermolysis bullosa, cerebral infarction, stroke being apoplexia cerebri, acute myocardial infarction and spinal cord injuries; pharmaceutical composition containing stem cells for treatment of epidermolysis bullosa, cerebral infarction, stroke being apoplexia cerebri, acute myocardial infarction and spinal cord injuries | | | MUAFEY Life Science Institute, Inc.
88273406 23 Jan 2019 | on 28 Jul 2020
| Cells for medical use; stem cells for medical purposes; pharmaceutical... Class 005 Class 005 Pharmaceutical Products The wording "MUAFEY" has no meaning in a foreign language. | | 
